A New Model for Quantitative In Vivo Microscopic Analysis of Thrombus Formation and Vascular Recanalisation: The Ear of the Hairless (hr/hr) Mouse

Summary

The alteration of rheological blood properties as well as deterioration of vascular perfusion conditions and cell-cell interactions are major determinants of thrombus formation. Herein, we present an experimental model which allows for quantitative in vivo microscopic analysis of these determinants during both thrombus formation and vascular recanalisation. The model does not require surgical preparation procedures, and enables for repeated analysis of identical microvessels over time periods of days or months, respectively. After i.v. administration of FITC-dextran thrombus formation was induced photochemically by light exposure to individual arterioles and venules of the ear of ten anaesthetised hairless mice. In venules, epiillumination induced rapid thrombus formation with first platelet deposition after 0.59 ± 0.04 min and complete vessel occlusion within 7.48 ±1.31 min. After a 24-h time period, 75% of the thrombosed venules were found recanalised. Marked leukocyte-endothelial cell interaction in those venules indicated persistent endothelial cell activation and/or injury, even after an observation period of 7 days. In arterioles, epi-illumination provoked vasomotion, while thrombus formation was significantly (p <0.05) delayed with first platelet deposition after 2.32 ± 0.22 min and complete vessel occlusion within 20.07 ±3.84 min. Strikingly, only one of the investigated arterioles was found recanalised after 24 h, which, however, did not show leukocyte-endothelial cell interaction. Heparin (300 U/kg, i.v.) effectively counteracted the process of thrombus formation in this model, including both first platelet deposition and vessel occlusion. We conclude that the model of the ear of the hairless mouse allows for distinct in vivo analysis of arteriolar and venular thrombus formation/ recanalisation, and, thus, represents an interesting tool for the study of novel antithrombotic and thrombolytic strategies, respectively.

• 1 Aronson DL, Thomas DP. Experimental studies on venous thrombosis: effect of coagulants, procoagulants and vessel contusion. Thromb Haemost 1985; 54: 866-870
• 2 Baker M, Wayland H. On-line volume flow rate and velocity profile measurements for blood in microvessels. Microvasc Res 1974; 07: 131-143
• 3 Barker JH, Hammersen F, Bondar I, Uhl E, Galla TJ, Menger MD, Mess-mer K. The hairless mouse ear for in vivo studies of skin microcirculation. Plast Reconstr Surg 1989; 83: 948-959
• 4 Belch JJ. The role of the white blood cell in arterial disease. Blood Coagul Fibrinolysis 1990; 1: 183-191
• 5 Bemat A, Lale A, Herbert JM. Aurin tricarboxylic acid inhibits experimental venous thrombosis. Thromb Res 1994; 74: 617-627
• 6 Chen C, Hanson SR, Lumsden AB. Boundary layer infusion of heparin prevents thrombosis and reduces neointimal hyperplasia in venous polytetra- fluoroethylene grafts without systemic anticoagulation. J Vase Surg 1995; 22: 237-247
• 7 Davidson SF, Brantley SK, Talbot PJ, Das SK. A functional model of mi- crovascular thrombosis. Plast Reconstr Surg 1990; 86: 579-581
• 8 Dodds WJ. Animal models for the evolution of thrombotic disease. Ann N Y Acad Sci 1987; 516: 631-635
• 9 Fagrell B, Eriksson SE, Malmstmm S, Sjjclund A. Computerized data analysis of capillary blood cell velocity in humans (Abstract). Int J Microcirc: Clin Exp 1988; 07: S40
• 10 Fareed J, Jeske W, Eschenfelder V, Iqbal O, Hoppensteadt D, Ahsan A. Pharmacologic validation of the clinical effects of an optimized low-molec- ular-weight heparin-reviparin. Semin Thromb Hemost 1995; 21: 212-227
• 11 Gralnick HR, Williams S, McKeown LP, Hansmann K, Fenton JW, Krutzsch H. High-affinity alpha-thrombin binding to platelet glycoprotein lb alpha: identification of two binding domains. Proc Natl Acad Sci USA 1994; 91: 6334-6338
• 12 Haines ST, Bussey HI. Thrombosis and the pharmacology of antithrombotic agents. Ann-Pharmacother 1995; 29: 892-905
• 13 Hanson SR, Kotze HF, Savage B, Harker LA. Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Arteriosclerosis 1985; 05: 595-603
• 14 Heiniger HJ, Borey JJ. In: Handbook of genetically standardized jax mice. Jackson Laboratories; Bar Harbor, USA: 1980
• 15 Herrmann KS. Platelet aggregation induced in the hamster cheek pouch by a photochemical process with excited fluorescein isothiocyanate-dextran. Microvasc Res 1983; 26: 238-249
• 16 Hirschberg M, Hofferberth B. New model of cerebral thrombosis in dogs. Stroke 1988; 19: 741-746
• 17 Jourdan A, Aguejouf O, Imbault P, Doutremepuich F, Inamo J, Doutreme-puich C. Experimental thrombosis model induced by free radicals. Application to aspirin and other different substances. Thromb Res 1995; 79: 109-123
• 18 Kamovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J Cell Biol 1965; 27: 137-138A
• 19 Laux V, Seiffge D. Platelet function in the dorsal skin fold chamber of the rat. In Vivo 1993; 7: 45-51
• 20 Perry DD, Reddick RL, Risco JM. Choroidal microvascular repair after argon laser photocoagulation. Ultrastructural observations. Invest Ophthalmol Vis Sci 1984; 25: 1019-1026
• 21 Piotrowicz RS, Orchekowski RP, Nugent DJ, Yamada KY, Kunicki TJ. Glycoprotein Ic-IIa functions as an activation-independent fibronectin receptor on human platelets. J Cell Biol 1988; 106: 1359-1364
• 22 Rosenblum WI. Biology of disease: Aspects of endothelial malfunction and function in cerebral microvessels. Lab Invest 1986; 55: 252-268
• 23 Rote WE, Wems SW, Davis JH, Feigen LP, Kilgore KS, Lucchesi BR. Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery. Cardiovasc Res 1993; 27: 500-507
• 24 Saniabadi AR, Umemura K, Matsumoto N, Sakuma S, Nakashima M. Vessel wall injury and arterial thrombosis induced by a photochemical reaction. Thromb Haemost 1995; 73: 868-872
• 25 Sato M, Ohshima N. Effect of wall shear rate on thrombogenesis in microvessels of the rat mesentery. Circ Res 1990; 66: 941-949
• 26 Seiffge D, Kremer E. Influence of ADP, blood flow velocity, and vessel diameter on the laser-induced thrombus formation. Thromb Res 1986; 42: 331-341
• 27 Siegel JM, Markou CP, Ku DN, Hanson SR. A scaling law for wall shear rate through an arterial stenosis. J Biomech Eng 1994; 116: 446-451
• 28 Stepnick DW, Hayden RE, Hogikyan ND. Development of thrombosis models in the rabbit. Arch Otolaryngol Head Neck Surg 1994; 120: 997-1002
• 29 Sugidachi A, Asai F, Tani Y, Hosokawa T, Koike H. Occlusive thrombosis in the femoral artery of the rabbit: a pharmacological model for evaluating antiplatelet and anticoagulant agents. Blood Coagul Fibrinolysis 1996; 7: 57-64
• 30 Umemura K, Kohno Y, Matsuno H, Uematsu T, Nakashima M. A new model for photochemically induced thrombosis in the inner ear microcirculation and the use of hearing loss as a measure for microcirculatory disorders. Eur Arch Otorhinolaryngol 1990; 248: 105-108
• 31 van derGiessenWJ, Mooi W, Rutteman AM, van VlietHH, Slager CJ, Verdouw PD. A new model for coronary thrombosis in the pig: preliminary results with thrombolysis. Eur Heart J 1983; 04 Suppl C 69-76
• 32 Weichert W, Pauliks V, Breddin HK. Laser-induced thrombi in rat mesenteric vessels and antithrombotic drugs. Haemostasis 1983; 13: 61-71
• 33 Yao SK, Akhtar S, Scott BurdenT, Ober JC, Golino P, Buja LM, Casscells W, Willerson JT. Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. Circulation 1995; 92: 1005-1010
• 34 Yokota K, Yamashita A, Oda M. Anti thrombotic activity of KBT-3022 in experimental models of thrombosis. Jpn J Pharmacol 1995; 68: 201-206
• 35 Zeintl H, Tompkins WR, Messmer K, Intaglietta M. Static and dynamic video analysis applied to clinical investigations. Prog Appl Microcir 1986; 11: 01-10